Denis Du Bois

Denis Du Bois is CEO of P5 Group, a cleantech marketing firm, and founding editor of Energy Priorities Magazine. He will moderate the MIT Enterprise Forum "Tech to Grid: How Technology Entrepreneurs Can Find Opportunities in the Smart Grid Revolution" in Bellevue November 10.

Recent posts

How the Smart Grid Opportunity Looks a Lot Like the Internet Once Did
The smart grid is a new technology arena that will change how Americans think about electricity. Entrepreneurs jumping into this sector give many reasons — to save the planet, save lives,... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Denis Du Bois

Recent posts

How the Smart Grid Opportunity Looks a Lot Like the Internet Once Did

Underwriters and Partners

The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

The Bay Area and Beyond: Biocom Talks Innovation and COVID

How to Approach Life Sciences Fundraising

Xconomy on Demand

We offer a number of ways to subscribe for free!